These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 8157945
1. Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems. Lijnen P, Celis H, Fagard R, Staessen J, Amery A. J Hypertens; 1994 Jan; 12(1):59-64. PubMed ID: 8157945 [Abstract] [Full Text] [Related]
2. Influence of cholesterol-lowering on plasma membrane lipids and function. Lijnen P, Echevaría-Vázquez D, Petrov V. Methods Find Exp Clin Pharmacol; 1996 Mar; 18(2):123-36. PubMed ID: 8740244 [Abstract] [Full Text] [Related]
3. Dietary calcium, blood pressure and cell membrane cation transport systems in males. Lijnen P, Petrov V. J Hypertens; 1995 Aug; 13(8):875-82. PubMed ID: 8557965 [Abstract] [Full Text] [Related]
4. Changes in plasma lipids, lipoproteins and apolipoproteins in hypercholesterolaemic patients treated with pravastatin. Lijnen P, Celis H, Desager JP, Fagard R. J Hum Hypertens; 1995 Jul; 9(7):557-64. PubMed ID: 7562885 [Abstract] [Full Text] [Related]
5. Transmembrane cationic fluxes in erythrocytes of diabetics and normal men. Lijnen P, Fenyvesi A. Methods Find Exp Clin Pharmacol; 1994 Jul; 16(1):37-47. PubMed ID: 8164472 [Abstract] [Full Text] [Related]
6. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia. Koter M, Franiak I, Broncel M, Chojnowska-Jezierska J. Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855 [Abstract] [Full Text] [Related]
7. Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocyte membranes. Rabini RA, Polenta M, Staffolani R, Tocchini M, Signore R, Testa I, Mazzanti L. Exp Mol Pathol; 1993 Aug; 59(1):51-7. PubMed ID: 8262165 [Abstract] [Full Text] [Related]
8. Efficacy and safety of pravastatin in hypertensive hypercholesterolaemic patients on antihypertensive drug therapy. Celis H, Lijnen P, Fagard R, Staessen J, Thijs L, Amery A. J Hum Hypertens; 1994 Jul; 8(7):525-30. PubMed ID: 7932517 [Abstract] [Full Text] [Related]
9. [Transport of monovalent cations into erythrocytes of rabbits with experimental hypercholesterolemia: correlation with plasma cholesterol]. Makarov VL, Kuznetsov SR, Churina SK, Sokolova AI. Biokhimiia; 1994 Jul; 59(7):1011-9. PubMed ID: 7948411 [Abstract] [Full Text] [Related]
10. [The comparison in vitro the effects of pravastatin and quercetin on the selected structural parameters of membrane erythrocytes from patients with hypercholesterolemia]. Broncel M, Franiak I, Koter-Michalak M, Duchnowicz P, Chojnowska-Jezierska J. Pol Merkur Lekarski; 2007 Feb; 22(128):112-6. PubMed ID: 17598654 [Abstract] [Full Text] [Related]
11. Relationship between erythrocyte cation transport systems and membrane and plasma lipids in healthy men. Lijnen P, Petrov V, Amery A. Am J Med Sci; 1994 Feb; 307 Suppl 1():S146-9. PubMed ID: 8141155 [Abstract] [Full Text] [Related]
12. [Effect of HMG-CoA reductase inhibitors on the erythrocyte membrane]. Rabini RA, Antosiewicz J, Staffolani R, Polenta M, Testa I, Mazzanti L. Boll Soc Ital Biol Sper; 1991 Feb; 67(2):129-35. PubMed ID: 1653578 [Abstract] [Full Text] [Related]
13. Effect of pravastatin on erythrocyte rheological and biochemical properties in poorly controlled Type 2 diabetic patients. Miossec P, Zkhiri F, Pariès J, David-Dufilho M, Devynck MA, Valensi PE. Diabet Med; 1999 May; 16(5):424-30. PubMed ID: 10342343 [Abstract] [Full Text] [Related]
14. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II. Arch Intern Med; 1993 Jun 14; 153(11):1321-9. PubMed ID: 8507122 [Abstract] [Full Text] [Related]
15. Erythrocyte and platelet cationic concentrations and transport systems in normal volunteers treated with carmoxirole. Lijnen P, Petrov V, Tjandramaga T, Verbesselt R, Amery A. Methods Find Exp Clin Pharmacol; 1993 Sep 14; 15(7):483-90. PubMed ID: 7902890 [Abstract] [Full Text] [Related]
16. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study. Mallon PW, Miller J, Kovacic JC, Kent-Hughes J, Norris R, Samaras K, Feneley MP, Cooper DA, Carr A. AIDS; 2006 Apr 24; 20(7):1003-10. PubMed ID: 16603852 [Abstract] [Full Text] [Related]
17. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients]. Fortschr Med; 1994 Feb 20; 112(5):57-64. PubMed ID: 8163252 [Abstract] [Full Text] [Related]
18. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients. Castaño G, Más R, Arruzazabala ML, Noa M, Illnait J, Fernández JC, Molina V, Menéndez A. Int J Clin Pharmacol Res; 1999 Feb 20; 19(4):105-16. PubMed ID: 10939028 [Abstract] [Full Text] [Related]
19. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy. Chan P, Lee CB, Lin TS, Ko JT, Pan WH, Lee YS. Am J Hypertens; 1995 Nov 20; 8(11):1099-104. PubMed ID: 8554733 [Abstract] [Full Text] [Related]
20. [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study]. Ferrari P, Weidmann P, Riesen WF, Martius F, Luban S, Pasotti E, Erne P, Fragiacomo C, Noseda G, Reutter F. Schweiz Med Wochenschr; 1993 Sep 18; 123(37):1736-41. PubMed ID: 8211024 [Abstract] [Full Text] [Related] Page: [Next] [New Search]